Aster Capital Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$500 Buy
+42
New +$994 ﹤0.01% 795
2025
Q2
Sell
-217
Closed -$2.91K 1652
2025
Q1
$2.91K Buy
217
+147
+210% +$2K ﹤0.01% 1158
2024
Q4
$1.02K Sell
70
-686
-91% -$9.59K ﹤0.01% 1009
2024
Q3
$9.49K Buy
+756
New +$8.23K ﹤0.01% 820

Other funds holding ZYME

Aster Capital Management's ZYME Position: Q1 2026 in Review

Aster Capital Management opened a new position in Zymeworks (ZYME) in Q1 2026: 42 shares worth $500. The stake represents ﹤0.01% of the portfolio and ranks #795 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in ZYME as recently as Q1 2025.

Aster Capital Management first reported a position in ZYME in Q3 2024 and has held it in 4 quarters since. The position peaked at $9.49K in Q3 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Aster Capital Management held 42 shares of Zymeworks worth $500 as of Q1 2026.
  • Zymeworks was a new Aster Capital Management position in Q1 2026.
  • Zymeworks made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #795 holding.
  • Aster Capital Management first reported a position in Zymeworks in Q3 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Zymeworks position peaked at $9.49K in Q3 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.